Linezolid for the Treatment of Patients with Confirmed MRSA Nosocomial Pneumonia in Nanjing, China- A Cost Effective Alternative to Vancomycin
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.183
https://www.valueinhealthjournal.com/article/S1098-3015(13)02088-3/fulltext
Title :
Linezolid for the Treatment of Patients with Confirmed MRSA Nosocomial Pneumonia in Nanjing, China- A Cost Effective Alternative to Vancomycin
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02088-3&doi=10.1016/j.jval.2013.08.183
First page :
A353
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
171